186 results on '"Koeber L"'
Search Results
2. Left atrial coupling index and undiagnosed atrial fibrillation in elderly high-risk individuals
3. Is frailty associated with greater symptom burden following catheter ablation for atrial fibrillation?
4. Long-term risk of cardiovascular side-effects following attention-deficit hyperactivity disorder treatment with sympathomimetic amines
5. Association between preeclampsia and long-term risk of arrhythmias
6. NT-pro-BNP pre TAVI and relationship with long-term outcomes
7. Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: determinants and relationship with patient-reported health status
8. Surgery in patients with infective endocarditis and prognostic importance of patient frailty
9. Perioperative atrial fibrillation in relation to major emergency abdominal surgery and non-perioperative new onset atrial fibrillation: is there a difference in outcome?
10. Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy
11. Temporal changes in stroke and heart failure following first-time atrial fibrillation/flutter in patients under 65 years of age: A Danish nationwide study
12. Validation of the GRACE 3.0 score and redefinition of the risk threshold for early invasive treatment in non-ST-segment elevation acute coronary syndromes: a modelling study from five countries
13. Mortality and heart failure in patients with a history of atrial fibrillation undergoing mitral valve surgery
14. The effect of empagliflozin on ketone bodies in patients with heart failure with reduced ejection fraction (Empire HF)
15. High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes
16. Duration of type 2 diabetes mellitus is associated with third-degree atrioventricular block - A Danish nationwide registry study
17. Long-term incidence of ischemic stroke following transient ischemic attack: a nationwide cohort study during 2014-2020
18. Anticoagulation-associated bleeding in patients randomised to screening for atrial fibrillation or usual care
19. Effect of implantable cardioverter-defibrillator in non-ischaemic systolic heart failure according to the Heart Failure Collaboratory Medical Therapy Score: extended follow-up of the DANISH trial
20. Impact of atrial fibrillation burden on longitudinal changes in left ventricular structure and function: a post-hoc analysis of a randomized clinical trial
21. Sarcoidosis is associated with a higher long-term risk of ischaemic heart disease, venous thromboembolism, and ischaemic stroke: a nationwide study
22. Biochemical profiles and risk of cardiovascular events in patients withType 2 Diabetes: implications for choice of novel antihyperglycemic therapy
23. Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation
24. Incidence of depression in type 2 diabetes patients with and without cardiovascular disease
25. Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study
26. Ventricular tachycardia predicts all-cause mortality and non-sudden cardiac death in non-ischaemic cardiomyopathy
27. PMHnet-alpha: development and validation of a neural network based discrete-time survival model for mortality prediction in ischemic heart disease
28. History of betablocker treatment breaks and risk of ventricular tachyarrhythmias among patients with heart failure and implantable cardioverter defibrillator: a nationwide cohort study
29. Prognosis and antithrombotic practice patterns in recurrent and transient atrial fibrillation following acute coronary syndrome: a nationwide study
30. Temporal trends in end-stage renal disease in patients with heart failure with or without diabetes: a nationwide study from 2002 to 2017
31. Incidence of atrial fibrillation/flutter, one-year re-admission rates, and practice patterns among patients <65 years of age: a Danish nationwide study
32. Long-term cardiovascular outcomes in five-year cancer survivors: a nationwide cohort study
33. Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
34. Perioperative atrial fibrillation in major emergency abdominal surgery: does it affect postoperative outcome?
35. Adherence and discontinuation of optimal heart failure therapies according to age
36. The impact of statins and RAS inhibitors on the association between delayed antidiabetic treatment and the risk of cardiovascular event in patients with a first HbA1c between 48–57 mmol/mol
37. Association between hemodialysis and patient characteristics, microbiological etiology, cardiac surgery, and mortality in patients with infective endocarditis: a nationwide study
38. Temporal changes in aortic valve replacement according to age in Denmark: nationwide data from 2008 to 2020
39. Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals
40. The value of coronary computed tomography and very early invasive coronary angiography compared to standard intervention in older patients after non-ST segment elevation acute coronary syndromes
41. Oral fluoroquinolones and risk of aortic dissection and aortic aneurysm: a nationwide nested case-control study
42. Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017
43. Cardiac resynchronisation therapy and implantable cardioverter-defibrillator in non-ischaemic systolic heart failure: extended follow-up of the DANISH trial
44. Rehospitalizations, repeated aortic surgery, and death in initial survivors of surgery for Stanford type A aortic dissection and the significance of age – a nationwide registry-based cohort study
45. First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function
46. Direct effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial
47. The risk spectrum of infective endocarditis among patients with congenital heart diseases
48. Mobitz type I 2nd degree atrioventricular (Wenckebach) block and cardiovascular death using 978,901 12 lead ECGs recordings
49. Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes
50. Temporal trends in the incidence of endocarditis among patients with a prosthetic heart valve: a nationwide study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.